Jump Financial, LLC Tcr2 Therapeutics Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.4 - $4.71 $130,800 - $256,695	-54,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.58 - $8.34 $249,610 - $454,530	54,500 New	54,500 $254,000
Q3 2021 Nov 12, 2021	SELL	$8.44 - $18.35 $114,395 - $248,715	-13,554 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.41 - $24.71 $222,421 - $334,919	13,554 New	13,554 $222,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.